Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
LNTH Stock Forecast 2025-2026
$74.75
Current Price
$5.10B
Market Cap
Buy 12
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to LNTH Price Targets
+112.7%
To High Target of $159.00
+73.9%
To Median Target of $130.00
+47.2%
To Low Target of $110.00
LNTH Price Momentum
-8.0%
1 Week Change
-26.1%
1 Month Change
-5.4%
1 Year Change
-16.4%
Year-to-Date Change
-41.1%
From 52W High of $126.89
+2.2%
From 52W Low of $73.11
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Lantheus (LNTH) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on LNTH and similar high-potential opportunities.
Latest LNTH Stock Price Targets & Analyst Predictions
Based on our analysis of 15 Wall Street analysts, LNTH has a bullish consensus with a median price target of $130.00 (ranging from $110.00 to $159.00). The overall analyst rating is Strong Buy (9.2/10). Currently trading at $74.75, the median forecast implies a 73.9% upside. This outlook is supported by 12 Buy, 1 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Richard Newitter at Truist Securities, suggesting a 47.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
LNTH Analyst Ratings
12
Buy
1
Hold
0
Sell
LNTH Price Target Range
Low
$110.00
Average
$130.00
High
$159.00
Current: $74.75
Latest LNTH Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for LNTH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 8, 2025 | Truist Securities | Richard Newitter | Buy | Maintains | $117.00 |
| Mar 21, 2025 | B. Riley Securities | Justin Walsh | Buy | Maintains | $122.00 |
| Feb 27, 2025 | Truist Securities | Richard Newitter | Buy | Maintains | $127.00 |
| Jan 14, 2025 | JMP Securities | David Turkaly | Market Outperform | Reiterates | $112.00 |
| Dec 18, 2024 | Goldman Sachs | Paul Choi | Buy | Initiates | $143.00 |
| Nov 8, 2024 | Truist Securities | Richard Newitter | Buy | Reiterates | $120.00 |
| Nov 7, 2024 | JMP Securities | David Turkaly | Market Outperform | Maintains | $112.00 |
| Sep 3, 2024 | Redburn Atlantic | Ed Ridley-Day | Buy | Initiates | $175.00 |
| Aug 1, 2024 | JMP Securities | David Turkaly | Market Outperform | Maintains | $125.00 |
| Aug 1, 2024 | Truist Securities | Richard Newitter | Buy | Maintains | $135.00 |
| Jul 25, 2024 | B. Riley Securities | Justin Walsh | Buy | Maintains | $146.00 |
| Jul 19, 2024 | Jones Trading | Justin Walsh | Buy | Maintains | $137.00 |
| Jul 11, 2024 | Truist Securities | Richard Newitter | Buy | Maintains | $141.00 |
| Jul 11, 2024 | Leerink Partners | Outperform | Maintains | $127.00 | |
| May 3, 2024 | Mizuho | Anthony Petrone | Buy | Maintains | $100.00 |
| May 3, 2024 | Truist Securities | Richard Newitter | Buy | Maintains | $96.00 |
| Apr 18, 2024 | B. Riley Securities | Justin Walsh | Buy | Maintains | $99.00 |
| Feb 26, 2024 | Truist Securities | Richard Newitter | Buy | Reiterates | $82.00 |
| Feb 23, 2024 | JMP Securities | David Turkaly | Market Outperform | Reiterates | $100.00 |
| Jan 10, 2024 | B. Riley Securities | Justin Walsh | Buy | Maintains | $95.00 |
Lantheus Holdings Inc. (LNTH) Competitors
The following stocks are similar to Lantheus based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Lantheus Holdings Inc. (LNTH) Financial Data
Lantheus Holdings Inc. has a market capitalization of $5.10B with a P/E ratio of 21.0x. The company generates $1.54B in trailing twelve-month revenue with a 16.5% profit margin.
Revenue growth is +0.8% quarter-over-quarter, while maintaining an operating margin of +27.4% and return on equity of +24.1%.
Valuation Metrics
Market Cap
$5.10B
Enterprise Value
$4.87B
P/E Ratio
21.0x
PEG Ratio
10.6x
Price/Sales
3.3x
Growth & Margins
Revenue Growth (YoY)
+0.8%
Gross Margin
+63.8%
Operating Margin
+27.4%
Net Margin
+16.5%
EPS Growth
-44.3%
Financial Health
Cash/Price Ratio
+18.1%
Current Ratio
5.7x
Debt/Equity
52.8x
ROE
+24.1%
ROA
+14.4%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Lantheus Holdings Inc. (LNTH) Business Model
About Lantheus Holdings Inc.
What They Do
Develops innovative diagnostic products for healthcare.
Business Model
Lantheus Holdings generates revenue by developing, manufacturing, and marketing diagnostic products, particularly in nuclear medicine. Their offerings, such as contrast agents and radiopharmaceuticals, enhance the precision of imaging techniques used by healthcare professionals to diagnose various medical conditions.
Additional Information
The company is focused on improving detection and diagnosis of critical diseases like cardiovascular issues and cancer. Lantheus is heavily invested in research and development, positioning itself as a leader in advancing diagnostic methodologies, thereby impacting healthcare systems worldwide.
Company Information
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
808
CEO
Mr. Brian A. Markison
Country
United States
IPO Year
2015
Website
www.lantheus.comLantheus Holdings Inc. (LNTH) Latest News & Analysis
Latest News
Quick Summary
Levi & Korsinsky is investigating Lantheus Holdings, Inc. (NASDAQ:LNTH) for potential federal securities law violations following its Q1 2025 financial results reported on May 7, 2025.
Why It Matters
The investigation into Lantheus Holdings for potential securities law violations could impact stock valuations, investor confidence, and future regulatory scrutiny.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Levi & Korsinsky is investigating Lantheus Holdings, Inc. (NASDAQ:LNTH) for potential federal securities law violations following its Q1 2025 financial results reported on May 7, 2025.
Why It Matters
The investigation into Lantheus Holdings for potential federal securities law violations may lead to stock volatility, affecting investor confidence and market valuation.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Levi & Korsinsky is investigating Lantheus Holdings, Inc. (NASDAQ:LNTH) for potential federal securities law violations following its Q1 2025 financial results reported on May 7, 2025.
Why It Matters
Lantheus Holdings faces a securities law investigation, which could impact stock performance and investor confidence, particularly following its recent financial results announcement.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Levi & Korsinsky has initiated an investigation into Lantheus Holdings, Inc. (NASDAQ: LNTH) for potential federal securities law violations following its Q1 2025 financial results.
Why It Matters
The investigation into Lantheus Holdings may indicate potential legal issues or financial mismanagement, raising risks for investors and impacting stock performance and valuation.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Levi & Korsinsky is investigating Lantheus Holdings, Inc. (NASDAQ: LNTH) for potential federal securities law violations following its Q1 2025 financial results announced on May 7, 2025.
Why It Matters
The investigation into Lantheus Holdings for potential securities law violations could signal financial instability, impacting stock performance and investor confidence.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Levi & Korsinsky has initiated an investigation into Lantheus Holdings, Inc. (NASDAQ: LNTH) for potential federal securities law violations following its Q1 2025 financial results.
Why It Matters
The investigation into Lantheus Holdings for potential securities law violations may lead to increased scrutiny, affecting stock performance and investor confidence.
Source: Accesswire
Market Sentiment:
Neutral
Frequently Asked Questions About LNTH Stock
What is Lantheus Holdings Inc.'s (LNTH) stock forecast for 2025?
Based on our analysis of 15 Wall Street analysts, Lantheus Holdings Inc. (LNTH) has a median price target of $130.00. The highest price target is $159.00 and the lowest is $110.00.
Is LNTH stock a good investment in 2025?
According to current analyst ratings, LNTH has 12 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $74.75. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for LNTH stock?
Wall Street analysts predict LNTH stock could reach $130.00 in the next 12 months. This represents a 73.9% increase from the current price of $74.75. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Lantheus Holdings Inc.'s business model?
Lantheus Holdings generates revenue by developing, manufacturing, and marketing diagnostic products, particularly in nuclear medicine. Their offerings, such as contrast agents and radiopharmaceuticals, enhance the precision of imaging techniques used by healthcare professionals to diagnose various medical conditions.
What is the highest forecasted price for LNTH Lantheus Holdings Inc.?
The highest price target for LNTH is $159.00 from at , which represents a 112.7% increase from the current price of $74.75.
What is the lowest forecasted price for LNTH Lantheus Holdings Inc.?
The lowest price target for LNTH is $110.00 from Richard Newitter at Truist Securities, which represents a 47.2% increase from the current price of $74.75.
What is the overall LNTH consensus from analysts for Lantheus Holdings Inc.?
The overall analyst consensus for LNTH is bullish. Out of 15 Wall Street analysts, 12 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $130.00.
How accurate are LNTH stock price projections?
Stock price projections, including those for Lantheus Holdings Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 23, 2025 4:00 AM UTC